Keywords: 35.3.3; 35.3.5; 35.3.7; 35.4.2;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: 35.2; 35.3.3; AVA; aortic valve area; AVAi; aortic valve area index; AVR; aortic valve replacement; LV; left ventricular;
Keywords: 22; 35.3.3; 35.3.7; 35.4.1CI, confidence interval; MV, mitral valve; RV, right ventricular; TR, tricuspid regurgitation; TS, tricuspid stenosis; TV, tricuspid valve
Keywords: 35.2; 35.3.3; 35.3.6AVR, aortic valve replacement; EPP, Edwards Prima Plus; SAV, stentless aortic valve
Keywords: 35; 35.2; 35.3.3; 35.3.4; AVR; aortic valve replacement; FTR; functional tricuspid regurgitation; NYHA; New York Heart Association; TMPG; transprosthetic mean pressure gradient; TR; tricuspid regurgitation;
Keywords: 35; 35.2; 35.3.3; 35.3.4; CPB; cardiopulmonary bypass; ICU; intensive care unit; PRBC; packed red blood cell; RACHS; Risk Adjustment for Congenital Heart Surgery;
Keywords: 35.2; 35.3.3; 35.3.4; AVR; aortic valve replacement; EMR; electronic medical record; SVD; structural valve deterioration;
Keywords: 24; 35.3.3; 35.3.4; AF; atrial fibrillation; CABG; coronary artery bypass grafting; HR; hazard ratio; INR; international normalized ratio; LV; left ventricular;
Right anterior minithoracotomy for aortic valve replacement: 10-year experience of a single center
Keywords: aortic valve replacement; minimally invasive aortic valve replacement; right anterior minithoracotomy; sutureless aortic valve prosthesis; AVR; aortic valve replacement; CABG; coronary artery bypass grafting; CI; confidence interval; CPB; cardiopulmonary
Early and intermediate outcome after aortic valve replacement with a sutureless bioprosthesis: Results of a multicenter study
Keywords: 35.2; 35.3.3; AVR; aortic valve replacement; CABG; coronary artery bypass grafting; CI; confidence interval; euroSCORE; European System for Cardiac Operative Risk Evaluation; OR; odds ratio; TAVR; transcatheter aortic valve replacement;
Single-center experience using the Freedom SOLO aortic bioprosthesis
Keywords: 35.2; 35.3.3; 35.3.6AVR, aortic valve replacement; CPB, cardiopulmonary bypass; euroSCORE, European System for Cardiac Operative Risk Evaluation; IVS, interventricular septum; LVEDD, left ventricular end-diastolic diameter; LVESD, left ventricular end-sys
A prospective “oversizing” strategy of the Edwards SAPIEN bioprosthesis: Results and impact on aortic regurgitation
Keywords: 35.2; 35.3.3; 35.3.5; 36.2; AR; aortic regurgitation; AVI; aortic valve implantation; LV; left ventricular; TA; transapical; TAVI; transcatheter aortic valve implantation; TEE; transesophageal echocardiography; TF; transfemoral; TTE; transthoracic echocar
Transapical transcatheter aortic valve-in-valve implantation: Clinical and hemodynamic outcomes beyond 2 years
Keywords: AVI, aortic valve implantation; AVR, aortic valve replacement; NYHA, New York Heart Association; TEE, transesophageal echocardiography35; 35.2; 35.3.3; 35.3.5
Early thrombosis risk in patients with biologic valves in the aortic position
Keywords: 35.2; 35.3.3; 35.3.6;
Surgical management of aortic root abscess: A 13-year experience in 172 patients with 100% follow-up
Keywords: 22; 35.2; 35.3.3; 35.3.4ARA, aortic root abscess; CABG, coronary artery bypass grafting; CI, confidence interval; IE, infective endocarditis; LCO, low cardiac output; NVE, native valve endocarditis; OR, odds ratio; PVE, prosthetic valve endocarditis
Long-term evaluation of biological versus mechanical prosthesis use at reoperative aortic valve replacement
Keywords: 35.2; 35.3.3; 35.3.4; AVR; aortic valve replacement; CI; confidence interval; HR; hazard ratio;
In vitro assessment of prosthesis type and pressure recovery characteristics: Doppler echocardiography overestimation of bileaflet mechanical and bioprosthetic aortic valve gradients
Keywords: 35; 35.2; 35.3.3; 35.3.4PMAX, maximum pressure gradient; PNET, net pressure gradient; PPR, pressure recovery; PPR%, percentage of maximum gradient composed of pressure recovery; PPR[1cm]%, percentage of pressure recovery complete 1 cm distal to valve
Magnetic resonance imaging versus echocardiography to ascertain the regression of left ventricular hypertrophy after bioprosthetic aortic valve replacement: Results of the REST study
Keywords: 35.2; 35.3.3; 36.2; 36.4; AS; aortic stenosis; AVR; aortic valve replacement; CABG; coronary artery bypass graft; LV; left ventricular; LVMI; left ventricular mass index; MRI; magnetic resonance imaging; REST; Left Ventricular Regression European Study; T
Tricuspid valve surgery: The past 10 years from the Nationwide Inpatient Sample (NIS) database
Keywords: 35.3; 35.3.3; 35.3.4; 35.3.7CABG, coronary artery bypass grafting; HCUP, Healthcare Cost and Utilization Project; ICD-9-CM, International Classification of Diseases, Ninth Edition, Clinical Modification; NIS, Nationwide Inpatient Sample; TV, tricuspid val
Transapical aortic valve implantation in patients with severely depressed left ventricular function
Keywords: 22; 28; 35.2; 35.3.3; CPB; cardiopulmonary bypass; LVEF; left ventricular ejection fraction;
Impact of patient–prosthesis mismatch after transcatheter aortic valve-in-valve implantation in degenerated bioprostheses
Keywords: 28.1; 35.2; 35.3.3; 35.3.5AR, aortic regurgitation; AVR, aortic valve replacement; BSA, body surface area; EOA, effective orifice area; iEOA, indexed effective orifice area; NYHA, New York Heart Association; PPM, patient–prosthesis mismatch; THV, transcat
Ten-year comparison of pericardial tissue valves versus mechanical prostheses for aortic valve replacement in patients younger than 60 years of age
Keywords: 35.2; 35.3.3; 35.3.4AVR, aortic valve replacement; EOAI, effective orifice area index; MAPEs, major adverse prosthesis-related events; PPM, patient–prosthesis mismatch; SVD, structural valve deterioration
Effect of sutureless implantation of the Perceval S aortic valve bioprosthesis on intraoperative and early postoperative outcomes
Keywords: 35.2; 35.3.3; AVR; aortic valve replacement; NYHA; New York Heart Association; TAV; transcatheter aortic valve;
Cardiac xenotransplantation technology provides materials for improved bioprosthetic heart valves
Keywords: 35; 35.3.3; 39.4α-Gal, galactose-α-1,3 galactose β-1,4-N-acetylglucosamine; BHV, bioprosthetic heart valve; GGTA1, α-1,3 galactosyltransferase; GSIB4, Griffonia simplicifolia–IB4; Ig, immunoglobulin; LVAD, left ventricular assist device; PBS, phosphate-bu
Redo aortic valve surgery: Influence of prosthetic valve endocarditis on outcomes
Keywords: 35.2; 35.3.3; 35.3.4; 41.1AVR, aortic valve replacement; CABG, coronary artery bypass grafting; CI, confidence interval; NYHA, New York Heart Association; OR, odds ratio; PVE, prosthetic valve endocarditis
St Jude Medical Epic porcine bioprosthesis: Results of the regulatory evaluation
Keywords: 35; 35.2; 35.3.3; 35.4.2; AVR; aortic valve replacement; LV; left ventricular; MVR; mitral valve replacement; SVD; structural valve deterioration;
Calcification of allograft and stentless xenograft valves for right ventricular outflow tract reconstruction: An experimental study in adolescent sheep
Keywords: 35.3.1; 35.3.3; 35.3.6; 35.5DW, dry weight; RVOT, right ventricular outflow tract
The Bentall procedure: Is it the gold standard? A series of 597 consecutive cases
Keywords: 26.1.4; 35.3.3; 35.3.4BV, biological valve; CABG, coronary artery bypass grafting; MV, mechanical valve; SMR, standardized mortality ratio
Sutureless aortic valve replacement with the Trilogy Aortic Valve System: Multicenter experience
Keywords: 35.2; 35.3; 35.3.3; AVR; aortic valve replacement; EOA; effective orifice area; TAC; Trilogy Attachment Clip; TCAT; Trilogy Crown Anchoring Tool; TSIT; Trilogy SecuRing Insertion Tool;